Pinaki Bhattacharjee

Research Fellow | National Institutes of Health | Medicinal Chemist | Organic Chemist | Enthusiastic Photographer

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Delighted to share our recent article exploring CB1 modulators: Unlocking Selenium Chemical Space via a Programmable Synthesis Platform Bearing Cannabinoid Receptor Recognition Motifs | Journal of the American Chemical Society https://t.co/1oajOy8TI8

https://t.co/KPvBvc3gPj

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Recent Publication on “Genetically Encoded CB2R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators” https://t.co/O9qQk7sG0P #mdpiijms via @IJMS_MDPI

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Happy to share our #publication :
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders - Metabolism - Clinical and Experimental

https://t.co/MTbyN5kdeu

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Excited to share our recent collaboration paper in #MolecularPsychiatry. Congratulations to Omar Soler-Cedeño , Zheng-Xiong Xi (NIDA) , Malliga R. Iyer and huge thanks to all co-authors involved in moving this work forward.

https://t.co/O57BItT5yn

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Rational Design, Synthesis, and Evaluation of Fluorescent CB2 Receptor Ligands for Live-Cell Imaging: A Comprehensive Review https://t.co/10JY1ctrZx #mdpipharmaceuticals via @Pharmaceut_MDPI

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Thrilled to share our latest publication in Journal of Medicinal Chemistry:

Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders | Journal of Medicinal Chemistry https://t.co/mxiz3s8wN7

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Therapeutic Potential of Vascular Adhesion Protein‐1 (VAP‐1)/Semicarbazide‐Sensitive Amine Oxidase (SSAO) Inhibitors: Current Medicinal Chemistry and Emerging Opportunities - Bhattacharjee - Medicinal Research Reviews - Wiley Online Library https://t.co/zSFIYLJTI9
#medchem

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Our latest publication is out now!A green synthetic approach to construct C2‐quaternary indolin‐3‐ones at room temperature via regioselective oxidative dearomatization of indoles -Bhattacharjee - European Journal of Organic Chemistry - Wiley Online Library https://t.co/u8P1D86ItQ

[Pinaki Bhattacharjee @Pinaki_Bhatta]

https://t.co/dkiG25sta7

[Pinaki Bhattacharjee @Pinaki_Bhatta]

@GANGULYIICB @CSIR_IND @HRDG_CSIR @csir_iicb Congratulations @GANGULYIICB Sir!!

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Check out our latest #publication.

Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders | Journal of Medicinal Chemistry https://t.co/vD9ugQn4eu

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Wow! It's cool to read an article where you know that your mentors have made significant contributions to #obesity and #metabolicdisease #drugdevelopment.

Novo tries a new trick on an old obesity target https://t.co/d1EtXX1n44 via @cenmag

[Pinaki Bhattacharjee @Pinaki_Bhatta]

One-Pot Synthesis of Thio-Augmented Sulfonylureas via a Modified Bunte’s Reaction https://t.co/F4nQ8YiFqL

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential https://t.co/yL9QwY4lix

[Pinaki Bhattacharjee @Pinaki_Bhatta]

https://t.co/m9RdGMHKk7

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The 2021 #NobelPrize in Chemistry has been awarded to Benjamin List and David W.C. MacMillan “for the development of asymmetric organocatalysis.”

[Pinaki Bhattacharjee @Pinaki_Bhatta]

@LanaRose786 @dubai37 @dubai39 Just awesome

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Wonderful Andaman..

[Pinaki Bhattacharjee @Pinaki_Bhatta]

CSIR-IICB

[Pinaki Bhattacharjee @Pinaki_Bhatta]

Happy Diwali 😄